GERBER, HOWARD M.D.
Dermatology · NPI 1003876285 · BELLAIRE, TX
GERBER, HOWARD is a Dermatology in BELLAIRE, TX, a member of 2 medical groups, who billed 25 distinct codes to Medicare Part B in 2024.
Groups: BELLAIRE DERMATOLOGY ASSOCIATES PA (BELLAIRE, TX) · SAGIS PLLC (HOUSTON, TX) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider analytics (2024)
GERBER, HOWARD billed 17,053 disclosed services in CY2023 and 15,006 in CY2024.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | premium | premium | premium | premium |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | premium | premium | premium | premium |
| 17003 | Destruction of precancer skin growth, 2-14 growths | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 17000 | Destruction of precancer skin growth, 1 growth | premium | premium | premium | premium |
| 11102 | Biopsy of related skin growth, first growth | premium | premium | premium | premium |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | premium | premium | premium | premium |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | premium | premium | premium | premium |
| 17110 | Destruction of skin growth, 1-14 growths | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 11103 | Biopsy of related skin growth, each additional growth | premium | premium | premium | premium |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | premium | premium | premium | premium |
| 99212 | Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | premium | premium | premium | premium |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | premium | premium | premium | premium |
| 88311 | Preparation of tissue for examination by removing any calcium present | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| Q0112 | All potassium hydroxide (koh) preparations | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 96567 | Application of light to destroy precancer skin growth | premium | premium | premium | premium |
| 11900 | Injection into skin growth, 1-7 growths | premium | premium | premium | premium |
| 10040 | Acne surgery | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 17004 | Destruction of precancer skin growth, 15 or more growths | premium | premium | premium | premium |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| 99202 | New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.